Your session is about to expire
← Back to Search
Does Ultrasound Assessment for Extravascular Lung Water and IVC Measurement Affect Outcomes in Inpatient Heart Failure Management?
N/A
Waitlist Available
Research Sponsored by Riverside University Health System Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
* Age \>18 admitted for acute decompensated heart failure exacerbation as primary admission diagnosis from Emergency department to General Medicine ward that are administered diuretic therapy expected to be admitted for two days or more.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during hospitalization typically one week
Awards & highlights
No Placebo-Only Group
Summary
This trial uses a daily device to help doctors control fluid levels in patients with serious heart conditions. The goal is to make better treatment choices and lower the risk of kidney problems.
Eligible Conditions
- Heart Failure
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ during hospitalization typically one week
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during hospitalization typically one week
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Kidney Failure
Secondary study objectives
Length of stay
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Daily POCUSExperimental Treatment1 Intervention
Patients are assessed by facility experts with daily chest ultrasound and findings of interstitial syndrome and IVC measurement are reported to primary care providers.
Group II: Usual careActive Control1 Intervention
Patients are assessed daily by primary care providers per usual care.
Find a Location
Who is running the clinical trial?
Riverside University Health System Medical CenterLead Sponsor
5 Previous Clinical Trials
1,417 Total Patients Enrolled